エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
First Edition BOGP (0)
ドイツ (2)
Advocacy (policy advocacy, lobbying)
Health technology Assessment (HTA) body (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Health Technology Assessment (HTA) activities